Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-II receptor blockers (ARB), the most commonly prescribed antihypertensive medications, counter renin-angiotensin-aldosterone system (RAAS) activation via induction of angiotensin-converting enzyme 2 (ACE2) expression. Consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Duvvuri, Venkata R., Baumgartner, Andrew, Molani, Sevda, Hernandez, Patricia V., Yuan, Dan, Roper, Ryan T., Matos, Wanessa F., Robinson, Max, Su, Yapeng, Subramanian, Naeha, Goldman, Jason D., Heath, James R., Hadlock, Jennifer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934012/
https://www.ncbi.nlm.nih.gov/pubmed/36817759
http://dx.doi.org/10.34133/hds.0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934012/
https://www.ncbi.nlm.nih.gov/pubmed/36817759
http://dx.doi.org/10.34133/hds.0002

Ejemplares similares